Clinical trials

#AI #Biopharmaceuticals #Clinical trials

Phesi collaborates with Alfasigma on clinical development

Phesi, provider of AI-based clinical development analytics products and solutions, is showcasing its data-driven clinical development approach at SCOPE Virtual Summit for Clinical Operations Executives 2021, in a case study session with international pharmaceutical company, Alfasigma. Phesi and Alfasigma are currently working together to maximise the value of priority medical… Read More

#News

#Clinical trials #Covid-19 #Immunology / Virology & Vaccines

COVID-19 vaccine pill a possibility?

Professor Sarah Gilbert, head of the team behind the Oxford AstraZeneca COVID-19 vaccine, has told UK MPs that there is a possibility the vaccine could be taken orally and perhaps also via a nasal spray. Reported in The Guardian newspaper today, she was asked by MP Graham Stringer how the… Read More

#Covid-19 #Editor's Choice #News #Trending News

#ATMP #Cell and gene therapy #Cell and Gene Therapy Catapult #Clinical trials

Report cites UK as internationally attractive for development of cell and gene therapies

The Cell and Gene Therapy Catapult (CGT Catapult) has published today the 2020 Advanced Therapy Medicinal Product (ATMP) clinical trials database and report, which show a marked 20% growth in the number of ATMP clinical trials across the UK. The number of commercially sponsored trials has shown a dramatic surge… Read More

#Editor's Choice #News

#Clinical trials #Covid-19 #Immunology / Virology & Vaccines

Sanofi and GSK start new Phase II study of their COVID-19 vaccine candidate

Sanofi and GlaxoSmithKline (GSK) have begun a new Phase II study with 720 volunteers aged 18 and over to select the most appropriate antigen dosage for Phase III evaluation of their adjuvanted recombinant protein COVID-19 vaccine candidate. “Over the past few weeks, our teams have worked to refine the antigen… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Biotechnology #Clinical trials #Drug development #Pharmaceutical

New psychedelic medicine COO looks to boost pharma and biotech collaborations

Beckley Psytech, a company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed Andy Page as its Chief Operating Officer. Page brings over 25 years’ experience working within global pharmaceutical and medtech organisations in strategic and operation roles. He started his career at SmithKline Beecham before joining… Read More

#Editor's Choice #News

#Clinical trials #Therapeutics

Clinical trial shows potential of MDMA therapy for addiction

Awakn Life Sciences has published results from its CMO Dr Ben Sessa’s Bristol Imperial MDMA in Alcoholism (BIMA) trial, an open-label safety, tolerability and proof-of-concept study investigating the potential role for MDMA therapy in treating patients with alcohol use disorder (AUD). Results published in the Journal of Psychopharmacology, show that… Read More

#Editor's Choice #News

#Clinical trials #CRO #Drug development

New partnership uses data to help drug developers with patient recruitment

Cerba Research, a healthcare diagnostic company, has formed a partnership with Biokortex, provider of digital solutions to the healthcare sector. This partnership will leverage patient biological and medical data to support drug developers and CROs with patient identification and recruitment activity. “Cerba Healthcare and Cerba Research are committed to investing… Read More

#Editor's Choice #News

#Clinical trials #Covid-19 #Human trials #Immunology / Virology & Vaccines

World’s first coronavirus Human Challenge study receives ethics approval

The UK will be the first country in the world to run a COVID-19 human challenge study, following approval from the UK’s clinical trials ethics body. Backed by a £33.6 million UK government investment, the first-of-its-kind study for this virus will involve establishing the smallest amount of virus needed to… Read More

#Covid-19 #Editor's Choice #News #Trending News

#AI / data analytics / healthtech / informatics #Clinical trials #Drug discovery #Pharmaceuticals #Rare disease #Therapeutics

The move towards patient-powered, data-driven rare disease drug discovery

By Rayne Rodgers, Vice President and Executive Director of MOVR for Muscular Dystrophy Association (MDA), and Sharon Hesterlee MDA’s Executive Vice President and Chief Research Officer. As an umbrella organisation representing those living with more than 40 types of neuromuscular disorders, the Muscular Dystrophy Association (MDA) contributes significantly to innovations… Read More

#Editor's Choice #Exclusive Content #News

#Clinical trials #Life sciences

eClinical Solutions reaches milestone with clinical data platform

eClinical Solutions, a global provider of cloud-based enterprise software and software-driven clinical data services, has revealed a more than 40% annual license growth of its elluminate Clinical Data Platform in 2020. This brings the total global adoption of elluminate to over 100 life sciences companies. elluminate helps life sciences companies… Read More

#News

#Clinical trials #Covid-19 #Immunology / Virology & Vaccines

Recruitment begins for Phase III trial of Janssen’s COVID-19 vaccine candidate

The University of Kentucky has been selected as a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase III clinical research study ENSEMBLE 2, which is evaluating the safety and efficacy of a two-dose regimen of Janssen’s COVID-19 vaccine candidate. The Phase III ENSEMBLE 2 study is… Read More

#Covid-19 #News

#Clinical trials #mRNA #Research & development

Clinical trials investigate treatment for diabetic eye disease

A new approach to treating one of the leading causes of blindness among patients with diabetes is being tested in clinical trials which begin this month. The trial involves 48 patient volunteers with diabetic macular oedema (DMO), a disease where blood vessels leak fluid into the retina. It is the… Read More

#Editor's Choice #News

#Clinical trials #Covid-19 #Immunology / Virology & Vaccines

Novavax announces rolling review for COVID-19 vaccine authorisation

Novavax has announced the start of the rolling review process for authorisation of NVX-CoV2373, its COVID-19 vaccine, by multiple regulatory agencies. The reviews will continue while the company completes its Phase III trials in the UK and US and through initial authorisation for emergency use granted under country-specific regulations. “The… Read More

#Covid-19 #Editor's Choice #News

#Clinical trials #Drug discovery

Clinical trial standard looks to provides global benchmark

GCSA is supporting the UK clinical research industry by providing an internationally-recognised quality benchmark for sites focused on attracting commercial clinical trials to bring the most innovative treatments to patients. Following the rapid approval of COVID-19 vaccines from both Pfizer-BioNTech and Oxford University/AstraZeneca, the UK’s ability to provide a world-leading… Read More

#News